ERBB2 and neoplasm: Although the majority of tumors lack estrogen/progesterone receptors (ER/PR) and HER2 amplification, unlike ductal or lobular types with triple-negative tumor molecular profile, ACCB does not exhibit an aggressive pathophysiology.